Cardiovascular effects of milrinone.

[1]  W. Colucci.  In vivo studies of myocardial beta-adrenergic receptor pharmacology in patients with congestive heart failure. , 1990, Circulation.

[2]  P. Ludmer,et al.  Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition. , 1988, The Journal of clinical investigation.

[3]  E. Braunwald,et al.  Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure. , 1986, Journal of the American College of Cardiology.

[4]  R. Cody,et al.  Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure. , 1986, Circulation.

[5]  E. Braunwald,et al.  Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. , 1986, Circulation.

[6]  D. Baim,et al.  Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. , 1985, Circulation.

[7]  E. Braunwald,et al.  Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease. , 1985, The American journal of cardiology.

[8]  E. Braunwald,et al.  Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. , 1985, The Journal of clinical investigation.